scPharmaceuticals Inc.
News
scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Globe Newswire BURLINGTON, Mass., Sept. 04, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...\n more…
Assenagon Asset Management S.A. Buys 52,870 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH)
Ticker Report Assenagon Asset Management S.A. increased its stake in shares of scPharmaceuticals Inc. (NASDAQ:SCPH - Free Report) by 266.7% in the 2nd quarter, according to its most recent 13F filing with the SEC...\n more…
scPharmaceuticals Breaks Below 200-Day Moving Average - Notable for SCPH
Market News Video In trading on Tuesday, shares of scPharmaceuticals Inc (SCPH) crossed below their 200 day moving average of 5.04, changing hands as low as 4.85 per share. scPharmaceuticals Inc shares are...\n more…
scPharmaceuticals (NASDAQ:SCPH) Given Buy Rating at HC Wainwright
Ticker Report HC Wainwright reissued their buy rating on shares of scPharmaceuticals (NASDAQ:SCPH - Free Report) in a research report sent to investors on Monday, Benzinga reports. The brokerage currently has a...\n more…
Buy Rating Affirmed: scPharmaceuticals's Revenue Surge and Product Development Promise
TipRanks Financial Blog Maxim Group analyst Naz Rahman reiterated a Buy rating on scPharmaceuticals (SCPH - Research Report) yesterday and set a price target of $20.00. Na...\n more…
Does scPharmaceuticals (SCPH) Have the Potential to Rally 291.9% as Wall Street Analysts Expect?
Zacks Investment Research scPharmaceuticals, Inc. (SCPH) closed the last trading session at $5.06, gaining 12.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set...\n more…